Cephalosporin resistance in ICU Escherichia coli: selection, plasmids and dosing
Escherichia coli isolates are collected from urine samples of patients in an intensive care unit. Disk diffusion testing with ceftriaxone is performed using a standardised inoculum and breakpoints. The percentage of isolates resistant to ceftriaxone is 12% in 2015, 38% in 2020 and 61% in 2024. Among the resistant isolates, 70% carry the gene blaCTX-M on a conjugative plasmid. In laboratory mating experiments, the plasmid is transferred by conjugation at a frequency of about 1 × 10−4 per donor cell. Ceftriaxone use in the hospital increased over the same period. A clinician says: “The bacteria learned to resist because we used the drug. If we simply use a much higher dose, they will not be able to cope.”
1. Explain the rise in resistance using natural selection rather than the idea that bacteria “learned” to resist.
Read the worked answer
The clinician's wording is Lamarckian. Bacteria do not acquire resistance because they need it or because they are exposed to the drug. Resistance arises from random mutations, such as mutations in the blaCTX-M gene or changes in porins and efflux pumps, that exist at low frequency before treatment. When ceftriaxone is used, susceptible cells are killed or inhibited, while cells carrying a resistance mutation survive and reproduce. The resistance allele is therefore passed to daughter cells, and its frequency in the population rises over generations. Increased ceftriaxone use intensifies this selection pressure and also gives resistant strains an advantage in treated patients. The population changes because of differential survival and reproduction, not because individual bacteria learn or adapt in a directed way.
2. Explain the role of the conjugative plasmid in the spread of resistance and why a transfer frequency of 1 × 10−4 can still be important.
Read the worked answer
The blaCTX-M gene is carried on a conjugative plasmid, so it can be transferred horizontally from a donor cell to a recipient cell during conjugation. A pilus brings the cells together, and a copy of the plasmid is passed to the recipient. The recipient then becomes resistant without inheriting the gene from a parent cell. A frequency of 1 × 10−4 per donor means one transfer per 10,000 donor cells under the test conditions, which sounds low. However, the gut and ICU environment can contain very high bacterial densities, so even a low per-cell frequency can produce many transfer events. The plasmid may also carry several resistance genes, so one transfer can confer multidrug resistance. Horizontal transfer accelerates spread beyond clonal reproduction and can move resistance between strains or species. Infection control, reduced crowding and antibiotic stewardship reduce opportunities for transfer.
3. Evaluate the proposal to use a much higher dose of ceftriaxone, and explain why disk diffusion zone sizes must be interpreted with care.
Read the worked answer
A higher dose may kill some low-level resistant bacteria, but it will not reliably overcome high-level resistance. blaCTX-M encodes an extended-spectrum β-lactamase that hydrolyses ceftriaxone, so increasing the drug concentration may simply provide more substrate for the enzyme. There is also a risk of toxicity and of selecting for strains with additional resistance mechanisms. The appropriate response is to culture the organism, determine its susceptibility with standardised breakpoints, and choose an effective agent, possibly a carbapenem, or use combination therapy. Disk diffusion must be interpreted cautiously: zone size depends on how quickly the antibiotic diffuses through the agar, the inoculum density, plate thickness and incubation conditions. Zone diameters for different antibiotics cannot be compared directly as a measure of potency because diffusion rates differ. The result should be read against validated breakpoints for that organism and drug, and, where dosing is critical, a minimum inhibitory concentration should be measured.